Shanghai HeartCare Medical Technology Corporation Limited engages in the research, development, manufacture, and sale of neuro-interventional medical devices in...
Shanghai HeartCare H1 FY26 profit climbs 18.5% to RMB 60.37 million; revenue rises 56.9% to RMB 291.03 million
Unbundling and Moving Up the Value Chain: A Structural View on HK's Long Tail
Shifting Gears: How Traditional Heavyweights and Green Pioneers Are Navigating a Transitioning Economy
Shanghai HeartCare Seeks Shareholder Approval for Sci-Tech Board A-Share Issuance
Shanghai HeartCare proposes bylaw amendments ahead of planned Shanghai STAR listing